Navigation Links
Roche Madison Moves to New Facility
Date:4/23/2009

ding pharmaceutical companies," he added.

"The scientific efforts in Madison are complementary to those at our other global RNA sites," said Lou Renzetti, Ph.D., global head, RNA Therapeutics at Roche. "Our colleagues in Madison have a lot to offer in terms of their expertise, which will significantly help our drug development efforts."

"These new lab facilities underscore both our commitment to the innovative talents of the team here at Roche Madison as well as to our pledge to explore and harness the potential of RNA-based therapeutics for complex diseases that are difficult to treat," said Lee Babiss, Ph.D., global head, Pharma Research at Roche.

About RNAi

RNAi (RNA interference) is a revolution in biology, representing a breakthrough in understanding how genes are turned on and off in cells. Its discovery was awarded the Nobel Prize in October 2006. By harnessing the natural biological process of RNAi occurring in our cells, the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon. RNAi therapeutics targets the cause of diseases by potently silencing specific messenger RNAs (mRNAs), thereby preventing disease-causing proteins from being made. RNAi therapeutics has the potential to treat disease and help patients in a fundamentally new way.

About Roche Madison

Roche Madison Inc. is a leader in the fields of RNA interference and gene therapy, based upon its expertise in non-viral nucleic acid chemistry and delivery. Effective and safe siRNA delivery represents the primary bottleneck to achieving therapeutic success using RNA interference. The company's Dynamic PolyConjugates(TM) (DPC) technology is being refined as an enabling nanotechnology platform for siRNA therapeutics, which makes it possible to target previously undruggable targets and has great potential for many diseases. DPCs represent a first in class polymer-based nano
'/>"/>

SOURCE Roche Madison Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services
2. Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
3. Roche Completes Tender Offer for Genentech
4. Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
5. SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
6. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
7. Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
8. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
9. Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.
10. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
11. InformationWeek Puts Roche Diagnostics on Top 500 Innovative Tech Users List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), ... royalty revenue from sales of Thalomid® during the ... $3.3 million. In addition, the Company anticipates ... for fiscal 2009. The difference in estimated ... be reflected in the fourth quarter financial results. ...
(Date:12/11/2009)... BOULDER, Colo., December 10, 2009 miRagen Therapeutics, ... lives by developing innovative microRNA-based therapeutics for cardiovascular ... data demonstrating that microRNA-206 (miR-206) plays a crucial ... (ALS or Lou Gehrig,s disease) and in neuromuscular ... in the December 11 issue of the journal ...
(Date:12/11/2009)... researchers have observed the "hot electron" effect in a ... the elusive charges using ultra-thin solar cells, opening a ... report in the current online edition of Applied ... solar cells, it generates free electrons in a range ... charges, the electrons must reach the bottom of the ...
(Date:12/11/2009)... 11 Algeta ASA (OSE: ALGETA), ... clinical center in the,US, the Tulane Cancer ... the phase III clinical study of Alpharadin ... prostate cancer,(CRPC) that has metastasized to the ... ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... GeoPharma, Inc. (Nasdaq:,GORX) (the "Company") announced today ... Company and Cura Pharmaceutical Co. (Cura). The,original ... Cura the,exclusive U.S. distribution rights of GeoPharma,s ... approval as a medical device.,The recent extension ...
... hosted at 2008 American Association for ... Clinical Chemistry Annual Meeting, SUNNYVALE, ... participate in the Company,s Analyst,Reception which is being hosted in ... (AACC) Annual Meeting., Cepheid speakers will include Chief Executive ...
... 21 Roche, the healthcare,company, announced today that it ... biotech company Genentech for US$89.00 per share,in cash, or ... of,Genentech other than Roche. Roche acquired a majority in ... shares., In a video interview Franz Humer, Roche ...
Other Biology Technology:GeoPharma Adds India, Nepal, Bangladesh, Sri Lanka and South Korea as New Distribution Channels for Mucotrol(TM) 2GeoPharma Adds India, Nepal, Bangladesh, Sri Lanka and South Korea as New Distribution Channels for Mucotrol(TM) 3Cepheid to Webcast Analyst Event 2
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3New source of classical techniques for blood-based studies in the laboratory mouse 2Alcohol May Help Protect Trauma Patients 58685 1Anti Aging Drug Closer to Reality 58683 1Anti Aging Drug Closer to Reality 58683 2International LDN Awareness Week October 19 25th 2009 58681 1International LDN Awareness Week October 19 25th 2009 58681 2International LDN Awareness Week October 19 25th 2009 58681 3International LDN Awareness Week October 19 25th 2009 58681 4International LDN Awareness Week October 19 25th 2009 58681 5
... brain develops, neurons reach out helter-skelter forming new connections, ... the brain chooses which connections to keep and which ... branches have the most electrical activity—a finding that could ... , The work, published in the April 21 issue ...
... subpopulation of the antibody-producing B cells of the immune ... of immunity -- innate and acquired, Duke University Medical ... B-1a and B-1b cells they have uncovered offers basic ... vaccines, they said. , B cells are the arms ...
... damage caused by diabetes could bring relief to millions ... also reduce the number of amputations of toes and ... are borne out long-term. Nerve disease in diabetes is ... Europe and North America. , Scientists at The University ...
Other Biology News:Confirmation of human protein interaction data by human expression data 2Specialized immune-system B cells play double-barreled role 2Specialized immune-system B cells play double-barreled role 3Diabetic nerve therapy shows 'striking' results 2
Bovine Pulmonary Artery Smooth Muscle Cells (BPASMC) (>500,000 cells)...
Image Acquisition and documentation system for fluorescent and non-fluorescent gels, membranes, blots, film, plates and assays...
... pixel digital color camera plus overhead UV ... The cabinet features built-in overhead UV with ... on two sides of the cabinet for ... Interior overhead white light is included ...
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Biology Products: